CDx Diagnostics - About the company
CDx Diagnostics is an acquired company based in Suffern (United States), founded in 1997 by Mark Rutenberg. It operates as a Provider of AI-based platform to detect precancerous tissues. CDx Diagnostics has raised $16M in funding. The company has 871 active competitors, including 264 funded and 172 that have exited. Its top competitors include companies like Natera, Guardant Health and Lunit.
Company Details
Provider of AI-based platform to detect precancerous tissues. The company uses proprietary platform technology WATS3d Biopsy to detect precancerous changes. The products of the company include OralCDx a non-invasive oral brush biopsy and EndoCDx a transepithelial laryngeal brush biopsy.
- Website
- www.cdxdiagnostics.com
- Social
- Phone Number
- +1 **********
- Registered Address
- Suffern, New York
Key Metrics
Founded Year
1997
Location
Suffern, United States
Stage
Acquired
Total Funding
$16M in 2 rounds
Latest Funding Round
Investors
Ranked
150th among 871 active competitors
Employee Count
109 as on Aug 31, 2026
Exit Details
Acquired by Galen Partners (Jul 11, 2017)
Legal entities associated with CDx Diagnostics
CDx Diagnostics is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
ORAL CANCER PREVENTION INTERNATIONAL, INC. CIN: 208473531 , United States, Active | Dec 31, 1999 | - | 108 (As on Dec 31, 2024) | - |
CDX DIAGNOSTICS, INC CIN: 20-8473531 , United States, Active | Dec 31, 2009 | - | 131 (As on Dec 31, 2020) | - |
CDx Diagnostics's acquisition details
CDx Diagnostics got acquired by Galen Partners on Jul 11, 2017.
Click here to take a look at CDx Diagnostics's acquisition in detail
Sign up to download CDx Diagnostics' company profile
CDx Diagnostics's funding and investors
CDx Diagnostics has raised a total funding of $16M over 2 rounds. Its first funding round was on Dec 16, 2019. CDx Diagnostics has 3 institutional investors.
Here is the list of recent funding rounds of CDx Diagnostics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 15, 2020 | 2965253 | Series A | 6257626 | 8135919 | 6414728 | 7720118 |
Dec 16, 2019 | 2054605 | Series A | 3235022 | 9831726 | 4160136 | 1034741 |
Access funding benchmarks and valuations. Sign up today!View details of CDx Diagnostics's funding rounds and investors
CDx Diagnostics' founders and board of directors
Founder? Claim ProfileThe founders of CDx Diagnostics is Mark Rutenberg.
Here are the details of CDx Diagnostics' key team members:
- Mark Rutenberg: Founder of CDx Diagnostics. Contact Info: 1 email address
- Bill Huffnagle: CEO of CDx Diagnostics.
View details of CDx Diagnostics's Founder profiles and Board Members
CDx Diagnostics' employee count trend
CDx Diagnostics has 109 employees as of Aug 26. Here is CDx Diagnostics's employee count trend over the years:
Uncover CDx Diagnostics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
CDx Diagnostics's Competitors and alternates
Top competitors of CDx Diagnostics include Natera, Guardant Health and Lunit. Here is the list of Top 10 competitors of CDx Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Natera 2004, Redwood City (United States), Public | Developer of cell-free DNA testing for oncology, women’s health, and organ health | $152M | 77/100 | |
2nd |  Guardant Health 2012, Redwood City (United States), Public | Developer of digital sequencing technology for cancer detection | $557M | 75/100 | |
3rd | Lunit 2013, Seoul (South Korea), Public | Developer of medical software for cancer screening and oncology diagnostics | $135M | 71/100 | |
4th | Foundation Medicine 2010, Cambridge (United States), Acquired | Provider of genomics-based diagnostics test for cancer | $96.5M | 70/100 | |
5th | Online platform for genetic and diagnostic health testing that helps identify health risks | $67.6M | 69/100 | ||
6th | BillionToOne 2015, San Francisco (United States), Public | Provider of cell-free cancer liquid biopsy test | $389M | 69/100 | |
7th | Provider of AI-powered diagnostic solutions for pathology | $114M | 68/100 | ||
8th | Myriad Genetics 1991, United States, Public | Developer of molecular diagnostics and personalized medicine for cancer | - | 68/100 | |
9th | Geneoscopy 2015, St. Louis (United States), Series C | Developer of non-invasive biomarker tests for colorectal cancer | $219M | 67/100 | |
10th | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 66/100 | |
150th | CDx Diagnostics 1997, Suffern (United States), Acquired | Provider of AI-based platform to detect precancerous tissues | $16M | 44/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on CDx Diagnostics's competitors? Click here to see the top ones
CDx Diagnostics's Investments and acquisitions
CDx Diagnostics has made no investments or acquisitions yet.
Reports related to CDx Diagnostics
Here is the latest report on CDx Diagnostics's sector:
News related to CDx Diagnostics
Filter this list•
WATS3D Adoption Accelerates as Cooper University Health Advances Esophageal Disease Early DetectionNewswire•Aug 13, 2025•CDx Diagnostics
•
CDx Diagnostics Receives FDA Breakthrough Device Designation for Its WATS3D Test System for Esophageal Cancer
Access Newswire•Jul 24, 2025•CDx Diagnostics
•
•
WATS3D® Significantly Boosts Barrett's Esophagus and Dysplasia Detection Rates in Landmark Clinical StudyPR Newswire•May 17, 2024•CDx Diagnostics
•
Avalon Healthcare Solutions’ Client BCBS of South Carolina Adds CDx Diagnostics as In-Network LabBusiness Wire•Jun 14, 2022•CDx Diagnostics, Avalon Healthcare Solutions
•
CDx Diagnostics’ WATS3D Receives “Medically Necessary” Designation From Highmark Health PlansBusiness Wire•Nov 17, 2021•CDx Diagnostics
•
CDx Diagnostics Contracts with Wellmark Blue Cross and Blue Shield for Barrett’s Esophagus and Esophageal Precancer Testing PlatformGlobeNewswire•May 03, 2021•CDx Diagnostics, Wellmark Blue Cross and Blue Shield
•
•
Lumeda Announces Appointment of Alexander Zinke as Chief Executive OfficerPRWeb•Oct 16, 2020•Lumeda, CDx Diagnostics
•
CDx Diagnostics Announces Contract with Hawaii Medical Services AssociationGlobeNewswire•Aug 11, 2020•CDx Diagnostics
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about CDx Diagnostics
Explore our recently published companies
- Integral Physical Therapy - Firestone based, 2016 founded, Funding Raised company
- Halal Travel AI - Unfunded company
- Denizalfredlegal - Unfunded company
- Park County Handyman - United States based, Unfunded company
- Lullaby Lexi - Unfunded company
- Vulcano Padel - Germany based, Unfunded company
